J 2017

Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic

MÁJEK, Ondřej, Jaroslava DUŠKOVÁ, Vladimír DVOŘÁK, Alena BEKOVÁ, Daniel KLIMEŠ et. al.

Basic information

Original name

Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic

Authors

MÁJEK, Ondřej (203 Czech Republic, guarantor, belonging to the institution), Jaroslava DUŠKOVÁ (203 Czech Republic), Vladimír DVOŘÁK (203 Czech Republic), Alena BEKOVÁ (203 Czech Republic), Daniel KLIMEŠ (203 Czech Republic, belonging to the institution), Milan BLAHA (203 Czech Republic, belonging to the institution), Ahti ANTTILA (246 Finland) and Ladislav DUŠEK (203 Czech Republic, belonging to the institution)

Edition

European Journal of Cancer Prevention, Philadelphia, Lippincott Williams Wilkins, 2017, 0959-8278

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.886

RIV identification code

RIV/00216224:14110/17:00096428

Organization unit

Faculty of Medicine

DOI

UT WoS

000398812900008

Keywords in English

mass screening; Pap smear; performance indicators; cervical cancer

Tags

Tags

International impact, Reviewed
Změněno: 20/3/2018 18:23, Soňa Böhmová

Abstract

V originále

In 2008, the organized Czech National Cervical Cancer Screening Programme (CNCCSP) was initiated by transformation of the existing opportunistic efforts. The aim of our study was to examine recent cervical cancer burden trends and to assess the quality of the Czech National Cervical Cancer Screening Programme using a set of standard performance indicators. Our study utilized data from the national Cervical Cancer Screening Registry and the Czech National Cancer Registry. We computed internationally accepted indicators and assessed time trends and variability among screening centres. Between 1995 and 2011, the incidence of age-standardized cervical cancer decreased by 21% (1023 cases in 2011), and the mortality decreased by 35% (399 deaths in 2011). The annual coverage of the target population by cervical screening increased to 56% in 2013 (as compared with 35% in 2001). If we consider a 2-year interval (2012–2013), the estimated coverage was 77%. Over two million women underwent screening in 2013; 96% of them had a negative result. About 0.2% of smears showed cytological signs of a high-grade intraepithelial lesion or a malignancy, and the estimated positive predictive value for advanced intraepithelial neoplasia (cervical intraepithelial neoplasia grade 2+) was 79.6%. However, performance indicators show considerable heterogeneity between screening centres. The reported values of performance indicators are in line with the results of programmes that have previously been shown to be successful in terms of decreasing the cervical cancer burden, and are promising with respect to an even more pronounced decrease in cervical cancer mortality in the near future, provided that continuous quality improvement can be maintained. Linkage studies between screening, cancer and cause-of-death registers can provide further information on screening effectiveness and validity issues.